The value of N-terminal proB-type natriuretic peptide for early identification of myocardial infarction in patients with high-risk non-ST-elevation acute coronary syndromes

Clinical Chemistry and Laboratory Medicine

Volumn 49, Issue 8, 2011, Pages 1359-1365

  Riezebos, Robert K ^a   Laarman, Gerrit J ^b   Tijssen, Jan G P ^c   Verheugt, Freek W A ^a  

^a ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^b Microvida Laboratory for Medical Microbiology and Immunology   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

acute coronary syndrome; myocardial infarction; N terminal proB type natriuretic peptide (NT proBNP); troponin

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; CREATINE KINASE MB; TROPONIN T;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; BIOCHEMISTRY; COHORT ANALYSIS; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; DEMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; EVALUATION; FEMALE; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME; PHYSICAL PARAMETERS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; ST SEGMENT ELEVATION;

ACUTE CORONARY SYNDROME; AGED; BIOLOGICAL MARKERS; COHORT STUDIES; CREATINE KINASE, MB FORM; EARLY DIAGNOSIS; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; ODDS RATIO; PEPTIDE FRAGMENTS; PROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; TROPONIN T;

EID: 80051767264     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2011.213     Document Type: Article

References (27)

1. Blankenberg S, Zeller T, Saarela O, Havulinna AS, Kee F, Tunstall-Pedoe H, et al. Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: The MONICA, risk, genetics, archiving, and monograph (MORGAM) biomarker project. Circulation 2010;121:2388-97.
2. Bassand JP, Hamm CW, Ardissino D, Boersma E, Budaj A, Fernandez-Alvilez F, et al. ESC guidelines on the diagnosis and treatment of non-ST segment elevation acute coronary syndromes. Eur Heart J 2007;28:1598-660.
3. Lindahl B, Toss H, Siegbahn A, Venge P, Wallentin L. Markers of myocardial damage and inflammation in relation to longterm mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. N Engl J Med 2000;343:1139-47.
4. Riezebos RK, Ronner E, de Boer BA, Slaats EH, Tijssen JG, Laarman GJ. Dynamics in NT-proBNP concentration in patients with NSTE-ACS. Am Heart J 2005;150:1255-9.
5. Sabatine MS, Morrow DA, de Lemos JA, Omland T, Desai MY, Tanasijevic M, et al. Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia. J Am Coll Cardiol 2004;44:1988-95. (Pubitemid 39473283)
6. Goetze JP, Christoffersen C, Perko M, Arendrup H, Rehfeld JF, Kastrup J, et al. Increased cardiac BNP expression associated with myocardial ischemia. FASEB J 2003;17:1105-7.
7. Sadanandan S, Cannon CP, Chekuri K, Murphy SA, Dibattiste PM, Morrow DA, et al. Association of elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarction. J Am Coll Cardiol 2004;44:564-8. (Pubitemid 39078180)
8. Riezebos RK, Ronner E, Tijssen JG, Laarman GJ. NT-ProBNP serum levels reflect severity and extent of ischemia in patients admitted with non-ST-elevation acute coronary syndrome. Acute Card Care 2006;8:51-7.
9. Navarro Estrada JL, Rubinstein F, Bahit MC, Rolandi F, Perez de Arenaza D, Gabay JM, et al. NT-probrain natriuretic peptide predicts complexity and severity of the coronary lesions in patients with non-ST-elevation acute coronary syndromes. Am Heart J 2006;151:1093e1-7.
10. Rittersma SZ, van der Wal AC, Koch KT. Plaque instability frequently occurs days or weeks before occlusive coronary thrombosis: A pathological thrombectomy study in primary percutaneous coronary intervention. Circulation 2005;111:1160-5. (Pubitemid 40365478)
11. Kurz K, Giannitsis E, Zehelein J, Katus HA. Highly sensitive cardiac troponin T values remain constant after brief exerciseor pharmacologic induced reversible myocardial ischemia. Clin Chem 2008;54:1234-8. (Pubitemid 352009701)
12. Keller T, Zeller T, Peetz D, Tzikas S, Roth A, Czyz E, et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009;361:868-77.
13. Alzuhairi KS, Hjortshøj S, Kristensen SR, Ravkilde J. A third troponin T blood sample is not cost-effective in patients with suspected non-ST segment elevation acute coronary syndrome. Scand J Clin Lab Invest 2011;71:117-22.
14. Weber M, Bazzino O, Navarro Estrada JL, Fuselli JJ, Botto F, Perez de Arenaza D, et al. N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission. J Am Coll Cardiol 2008;51:1188-95. (Pubitemid 351382099)
15. Riezebos RK, Ronner E, Ter Bals E, Slagboom T, Smits PC, ten Berg JM, et al. Immediate versus deferred coronary angioplasty in non-ST-elevation acute coronary syndromes. Heart 2009;95:807-12.
16. Yeo KT, Wu AH, Apple FS, Kroll MH, Christenson RH, Lewandrowski KB, et al. Multicentre evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay. Clin Chim Acta 2003;338:107-15. (Pubitemid 37456696)
17. Hallermayer K, Klenner D, Vogel R. Use of recombinant human cardiac troponin T for standardization of third generation troponin T methods. Scand J Clin Lab Invest 1999;Suppl 230:128-31. (Pubitemid 29279365)
18. Thygesen K, Alpert JS, White HD; Joint ESC/ACCF/AHA/ WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur Heart J 2007;20:2525-38.
19. Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, et al. The TIMI risk score for unstable angina/non-ST-elevation MI: A method for prognostication and therapeutic decision-making. J Am Med Assoc 2000;284:835-42. (Pubitemid 30643610)
20. Khan SQ, Quinn P, Davies JE, Ng LL. N-terminal pro-B-type natriuretic peptide is better than TIMI risk score at predicting death after acute myocardial infarction. Heart 2008;94:40-3.
21. Eggers KM, Lagerqvist B, Venge P, Wallentin L, Lindahl B. Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome. J Am Coll Cardiol 2009;54:357-64.
22. Bassan R, Potsch A, Maisel A, Tura B, Villacorta H, Nogueira MV, et al. B-type natriuretic peptide: A novel early blood marker of acute myocardial infarction in patients with chest pain and no ST-segment elevation. Eur Heart J 2005;26:234-40. (Pubitemid 40222361)
23. Goetze JP, Gore A, Møller CH, Steinbrüchel DA, Rehfeld JF, Nielsen LB. Acute myocardial hypoxia increases BNP gene expression. FASEB J 2004;15:1928-30. (Pubitemid 39602287)
24. Baggish AL, van Kimmenade RR, Januzzi JL Jr. The differential diagnosis of an elevated amino-terminal pro-B-type natriuretic peptide level. Am J Cardiol 2008;101:43-8.
25. Kim H, Yang DH, Park Y, Han J, Lee H, Kang H, et al. Incremental prognostic value of C-reactive protein and N-terminal proB-type natriuretic peptide in acute coronary syndrome. Circ J 2006;70:1379-84. (Pubitemid 44672891)
26. Galasko GI, Lahiri A, Barnes SC, Collinson P, Senior R. What is the normal range for N-terminal pro-brain natriuretic peptide? How well does this normal range screen for cardiovascular disease. Eur Heart J 2005;26:2269-76. (Pubitemid 41541390)
27. Januzzi JL Jr, Bamberg F, Lee H, Truong QA, Nichols JH, Karakas M, et al. High-sensitivity troponin T concentrations in acute chest pain patients evaluated with cardiac computed tomography. Circulation 2010;121:1227-34.